Introduction {#s1}
============

The embryonic body plan first emerges during gastrulation, when the three primordial germ layers --- ectoderm, mesoderm, and endoderm --- are formed and shaped, and embryonic axes are morphologically manifest. At this time, the anteroposterior (AP) body axis undergoes dramatic extension, a process that is essential for proper body plan formation and neural tube closure ([@bib81]; [@bib13]). Axial extension results from highly conserved convergence and extension (C and E) movements that simultaneously elongate tissues along the AP axis and narrow them in the orthogonal mediolateral (ML) dimension ([@bib36]; [@bib84]; [@bib37]). This process is driven in vertebrate embryos by a combination of highly polarized cell behaviors, including mediolateral intercalation behavior (MIB) and directed migration ([@bib36]; [@bib84]). MIB entails the ML alignment and elongation of cells and the acquisition of bipolar protrusive behavior through which cells intercalate in a polarized fashion between their anterior and posterior neighbors ([@bib62]; [@bib63]).

This ML polarization of cells and their behaviors requires planar cell polarity (PCP) signaling ([@bib80]; [@bib52]; [@bib34]; [@bib82]; [@bib83]; [@bib89]; [@bib30]; [@bib38]; [@bib73]; [@bib70]). First discovered in *Drosophila*, this conserved signaling network is essential for collective polarity across cellular fields, within the plane of a tissue ([@bib79]; [@bib68]). Core PCP components acquire asymmetric distribution within cells ([@bib3]), with some becoming enriched at the anterior or posterior aspects of vertebrate cells as they undergo gastrulation movements ([@bib83]; [@bib55]; [@bib9]; [@bib90]). Because impairment of PCP signaling dramatically disrupts the polarized cell behaviors underlying axis extension but has little effect on patterning, it is thought to act as a molecular compass that allows cells to sense and/or respond to positional cues within the embryo ([@bib91]; [@bib24]). This implies the existence of a molecular mechanism by which patterning information is communicated to this compass, and ultimately to the cellular machinery that drives polarized C and E cell behaviors.

In contrast with vertebrate embryos, PCP signaling is not essential for axial extension in *Drosophila*, which instead requires AP patterning that confers the striped expression of pair-rule genes ([@bib32]; [@bib92]). These in turn regulate the expression of Toll-like receptors in a partially overlapping striped pattern, comprising a positional code along the extending AP axis ([@bib51]). AP patterning is similarly a prerequisite for extension of the gut tube in *Drosophila* and *Xenopus*, and during *Xenopus* gastrulation ([@bib50]; [@bib35]; [@bib40]). In particular, [@bib50] reported that *Xenopus* gastrula explants with different AP positional values extend when apposed ex vivo, whereas those with the same positional identity do not. Notably, these positional values could be recapitulated in explants by different doses of the TGFβ ligand Activin ([@bib50]), which signals largely via the Nodal signaling pathway during early vertebrate embryogenesis ([@bib53]). These results demonstrate that AP patterning is required for axial extension ex vivo and implies a crucial role for Nodal signaling at this intersection of tissue patterning and morphogenesis in vivo.

Nodal is a TGFβ-superfamily morphogen whose graded signaling within the embryo produces discrete developmental outcomes depending on a cell's position within that gradient and the resulting signaling level/duration to which it is exposed ([@bib17]; [@bib27]; [@bib77]; [@bib16]; [@bib6]). Upon binding of Nodal--Gdf3 (Vg1) heterodimers ([@bib54]; [@bib5]; [@bib47]), the receptor complex --- comprised of two each of the Type I and Type II serine-threonine kinase receptors Acvr1b and Acvr2b and the co-receptor Tdgf --- is activated and phosphorylates the downstream transcriptional effectors Smad2 and/or Smad3 ([@bib25]; [@bib59]). Nodal signaling is essential for specification of endoderm and mesoderm germ layers and their patterning along the AP axis, with the highest signaling levels producing endoderm and the most dorsal/anterior mesoderm fates ([@bib71]; [@bib26]; [@bib78]; [@bib15]; [@bib19]; [@bib20]). Mouse embryos that are mutant for Nodal signaling components fail to gastrulate, resulting in early embryonic lethality ([@bib11]). Nodal-deficient zebrafish undergo highly abnormal gastrulation, failing to specify endoderm and most mesoderm ([@bib16]; [@bib25]; [@bib19]), resulting in embryos that are comprised largely of neuroectoderm and displaying severe neural tube and axis extension defects ([@bib1]; [@bib22]).

Restoration of mesoderm to maternal-zygotic *one-eyed pinhead* (MZ*oep*) zebrafish mutants, which lack the essential Tdgf Nodal co-receptor ([@bib25]), improves AP axis length and the morphology of the neural tube ([@bib2]), implying that Nodal promotes C and E of the neuroectoderm non-autonomously via specification of mesoderm. However, additional evidence points to a more direct role for Nodal signaling in C and E cell behaviors. First, Activin signaling via Nodal receptors is sufficient for C and E of *Xenopus* animal cap explants ([@bib50]; [@bib69]; [@bib31]) and for the underlying planar polarity of cells ([@bib64]). Furthermore, knockdown of two out of six *Xenopus* Nodal ligands disrupts C and E movements without affecting mesoderm specification ([@bib44]). Nodal and Activin were also shown to promote translocation of the core PCP component Disheveled to cell membranes, suggesting that it acts upstream of PCP signaling activation ([@bib50]; [@bib74]). Further evidence suggests that AP patterning is required in addition to PCP for C and E morphogenesis ([@bib50]), and while such patterning can be recapitulated by graded exposure of explants to Activin, it is not known whether Nodal and/or other signals play this role in vivo. Therefore, how Nodal interfaces with the PCP molecular compass during gastrulation remains to be determined.

Here, we investigate the role of Nodal signaling in C and E gastrulation movements in zebrafish. We demonstrate that defective C and E movements in the neuroectoderm of MZ*oep* mutant gastrulae are associated with reduced ML cell alignment and protrusive activity. Transplantation of mutant cells into the prospective neuroectoderm of wild-type (WT) embryos only partially restored their ML polarity during gastrulation, demonstrating both cell-autonomous and non-autonomous roles for Nodal in planar cell polarization. Surprisingly, MZ*oep*^--/--^ neuroectoderm cells exhibited normal, anteriorly biased localization of Prickle-GFP, a hallmark of PCP signaling activity. Consistent with active PCP signaling in the absence of Nodal, C and E defects in MZ*oep* mutants were exacerbated by interference with the core PCP component Vangl2. To examine further this cell-autonomous function of Nodal signaling in morphogenesis, we employed zebrafish blastoderm explantation to isolate the effects of Nodal from endogenous signaling centers of intact embryos. We found that, as for Nodal and Activin in *Xenopus* animal cap assays, expression of Nodal ligands was sufficient to induce robust, PCP-dependent ML cell polarization and C and E of naïve zebrafish blastoderm explants in culture. Treatment of explants with a Nodal inhibitor revealed a continuous requirement for Nodal signaling in ex vivo extension after mesoderm was specified and even in the absence of mesoderm, implying a primary, mesoderm-independent role for Nodal in C and E. Together, these data support a model in which Nodal signaling promotes ML cell polarity and C and E, both upstream and independent of PCP signaling, and predicts additional AP patterning mechanisms that instruct the PCP compass during vertebrate gastrulation.

Results {#s2}
=======

Nodal regulates C and E cell behaviors cell-autonomously and non-autonomously {#s2-1}
-----------------------------------------------------------------------------

Zebrafish embryos that are double mutant for the two *nodal*-related genes expressed during gastrulation, *ndr1* (*sqt*) and *ndr2* (*cyc*), or that lack both maternal and zygotic function of the co-receptor Tdgf (MZ*oep^--/^*^﻿--^) or the downstream effector Smad2, exhibit severe dorsolateral mesendoderm deficiencies and impaired AP extension of the enlarged neuroectoderm ([@bib16]; [@bib25]; [@bib19]; [Figure 1A](#fig1){ref-type="fig"}). However, underlying cell behavior defects during gastrulation have not been fully characterized. We therefore analyzed cell movements in the dorsal region of WT and MZ*oep* mutants by time-lapse confocal microscopy for a period of three hours, beginning shortly after the onset of C and E movements (80% epiboly, 8.5 hr post-fertilization \[hpf\]). Automated tracking of fluorescently labeled nuclei in WT gastrulae revealed clear convergence of cells from lateral positions toward the dorsal midline, and concomitant extension along the AP axis ([Figure 1B--C](#fig1){ref-type="fig"}, top, [Video 1](#video1){ref-type="video"}). Analysis of cell velocities demonstrated that rates of cell movement were highest in the lateral-, anterior-, and posterior-most regions of the gastrula and lowest in the center ([Figure 1D](#fig1){ref-type="fig"}, top). This is consistent with mediolateral intercalation, which is characterized by a stationary point near the embryo's equator and cell velocities that increase proportionally with their distance from this point ([@bib21]; [@bib10]). MZ*oep* mutant gastrulae, by contrast, exhibited disorganized cell movement and velocity patterns that are inconsistent with ML intercalation ([Figure 1B--D](#fig1){ref-type="fig"}, bottom). These cells moved along swirling paths, which contrasted with the direct anterior-, posterior-, and medial-ward movement of WT cells, and were seen to cross the dorsal midline, which was not observed in WT embryos ([Figure 1B](#fig1){ref-type="fig"}; [@bib10]).

![Nodal signaling regulates convergence and extension gastrulation cell behaviors.\
(**A**) Bright-field images of live WT and MZ*oep*^--/--^ embryos at 80% epiboly (8.5 hpf). The arrowheads indicate the point of view (dorsal side) for all fluorescent confocal micrographs. (**B--D**) Representative images of automated tracking of fluorescently labeled nuclei in the dorsal hemisphere of WT (top) and MZ*oep*^--/--^ (bottom) gastrulae. Tracks represent cell movements over three hours of time-lapse confocal imaging, beginning at 8.5 hpf, and are colored according to their displacement in the mediolateral (**B**) and anteroposterior (**C**) dimensions or the mean velocity of cell movement (**D**). Dotted lines indicate dorsal midline. (**E, F**) Displacement of cell tracks in the mediolateral (**E**) and anteroposterior (**F**) dimensions in WT (blue) and MZ*oep*^--/--^ (purple) gastrulae \[as shown in (**B--D**\]). Each dot represents a single cell track, each color represents an individual embryo, N = 4 WT and 5 MZ*oep*^--/--^. (**G**) Absolute displacement of cell tracks in ML (top) and AP (bottom) dimensions. Bars are mean with 95% confidence interval, p\<0.0001, Kolmogorov-Smirnoff (K-S) tests. (**H**) Representative images of membrane-labeled neuroectoderm in live WT (top) and MZ*oep^--/^*^--^ (bottom) gastrulae with cells outlined in yellow. (**I, J**) Neuroectoderm cell elongation (**I**) and alignment (**J**) at 8.5 hpf (left) and 10 hpf (right). Each dot represents a single cell, black bars are mean values in (**I**), and median values in (**J**). N = 3 embryos of each genotype, p\<0.0001, Mann-Whitney test in (**I**), K-S test in (**J**). (**K**) Representative images of membrane-labeled donor cells of the indicated genotypes within the neuroectoderm of unlabeled host gastrulae. N indicates the number of embryos analyzed from three independent trials. (**L**) Representative images of protrusions (arrowheads) made by transplanted neuroectoderm cells of the genotypes/conditions indicated in (**K**). (**M**) The orientation of all protrusions between 8.5 and 10 hpf is shown in radial histograms divided into 20° bins, with 0 and 180 representing the ML axis. Yellow and gray quadrants represent ML- and AP-oriented protrusions, respectively. \*\*, p=0.0053; \*\*\*\*, p\<0.0001; Chi-square. (**N**) Alignment of donor cells as in (**J**). The number of embryos in each condition is indicated in the corresponding panels in (**K**). Anterior is up in all images, scale bars are 50 μm. Dotted lines in (**J, N**) show 20 degrees from ML for reference.](elife-54445-fig1){#fig1}

###### Automated tracking of fluorescent nuclei in live zebrafish gastrulae.

Time-lapse confocal series from approximately 8.5 to 11.5 hpf in representative WT (left) and MZ*oep*^--/--^ (right) gastrulae injected with *H2B-RFP* RNA. Cell tracks shown below are colored according to track displacement, with warmer colors indicating higher displacement.

Both C and E movements were apparent in WT gastrulae when cell track displacement in the ML or AP dimension was plotted against the starting position of each cell along these respective axes ([Figure 1E--F](#fig1){ref-type="fig"}). For example, cells on the left side of each embryo exhibited right-ward displacement and vice versa as they converged toward the midline, resulting in a negative slope ([Figure 1E](#fig1){ref-type="fig"}, blue). Meanwhile, cells in the anterior and posterior of each embryo moved anteriorly and posteriorly, respectively, extending the AP axis and yielding a positive slope ([Figure 1F](#fig1){ref-type="fig"}, blue). Cell track displacement in MZ*oep*^--/--^ gastrulae, on the other hand, was not neatly graded along the ML and AP embryonic axes as observed in WT embryos ([Figure 1E--F](#fig1){ref-type="fig"}, purple). Although convergence was still apparent in these mutants ([Figure 1E](#fig1){ref-type="fig"}), displacement of MZ*oep*^--/--^ cells in the ML dimension was significantly reduced compared to WT ([Figure 1G](#fig1){ref-type="fig"}, p\<0.0001, Kolmogorov-Smirnov \[K-S\] test), and AP extension was particularly severely disrupted in terms of both absolute displacement and spatial organization of cell movements ([Figure 1F--G](#fig1){ref-type="fig"}). Although these results are consistent with previous findings that convergence movements are observed within Nodal-deficient gastrulae despite an almost complete lack of extension ([@bib25]; [@bib19]), they demonstrate that convergence movements are also reduced and disorganized in MZ*oep* mutant gastrulae ([Figure 1E--G](#fig1){ref-type="fig"}).

We next used a fluorescent membrane marker to assess the ML cell elongation, alignment and protrusive activity underlying C and E in the neuroectoderm of WT and MZ*oep*^--/--^ embryos from 8.5 hpf until the end of gastrulation (10 hpf) ([Figure 1H--M](#fig1){ref-type="fig"}). Cell elongation is represented as the aspect ratio of each cell (major/minor cell axis), and cell alignment was measured as the orientation of each major cell axis with respect to the embryo's ML axis, with 0° indicating perfect ML orientation. We found that WT neuroectoderm cells were significantly more elongated than MZ*oep*^--/--^ cells throughout gastrulation ([Figure 1I](#fig1){ref-type="fig"}; p\<0.0001, Mann-Whitney tests). Unlike the marked ML alignment of WT cells that increased over time ([Figure 1J](#fig1){ref-type="fig"}, blue), MZ*oep*^--/--^ cells were significantly less well aligned at both 8.5 and 10 hpf time points ([Figure 1J](#fig1){ref-type="fig"}, purple) (p\<0.0001, K-S test). We then measured the orientation of cellular protrusions within the neuroectoderm of WT and MZ*oep*^--/--^ gastrulae using cell transplantation to achieve sparse labeling ([Figure 1K--M](#fig1){ref-type="fig"}). Protrusions made by WT cells exhibited a strong ML bias typical of MIB ([Figure 1L--M](#fig1){ref-type="fig"}; [@bib36]), whereas protrusions of MZ*oep*^--/--^ cells were essentially randomly oriented with a slight anterior bias ([Figure 1L--M](#fig1){ref-type="fig"}). Together, these results demonstrate a severe disruption of C and E movements and polarized cell behaviors in MZ*oep* mutant gastrulae.

Previous studies have shown that axis extension can be largely rescued by restoration of mesoderm to MZ*oep* mutant embryos ([@bib2]), but the autonomy of Nodal signaling within the neuroectoderm has not been examined at the level of cell polarity. To determine whether Nodal regulates ML alignment cell-autonomously within the neuroectoderm, we transplanted membrane-labeled MZ*oep*^--/--^ cells into the prospective neuroectoderm of WT host embryos ([Figure 1K](#fig1){ref-type="fig"}). We then measured donor cell alignment at late gastrulation (10 hpf) and found that MZ*oep*^--/--^ cells within WT hosts were significantly less well aligned than WT control donors ([Figure 1N](#fig1){ref-type="fig"}; p\<0.0001, K-S test). At mid-gastrulation (8.5 hpf), some experiments showed that the alignment of MZ*oep*^--/--^ donor cells was not significantly different from that of WT donor cells in WT hosts ([Figure 1N](#fig1){ref-type="fig"}), whereas other experiments indicated that MZ*oep*^--/--^ donor cells were significantly less well aligned than WT controls at this stage ([Figure 2D](#fig2){ref-type="fig"}; p\<0.001, K-S test). Because cell alignment in unmanipulated WT gastrulae ([Figure 1J](#fig1){ref-type="fig"}) more closely resembles that of the WT control donors shown in [Figure 2D](#fig2){ref-type="fig"}, we conclude that the alignment of MZ*oep*^--/--^ cells within WT hosts is reduced compared to WT control donors. Notably, mutant cells in WT host gastrulae were significantly better aligned than MZ*oep*^--/--^ cells in MZ*oep*^--/--^ hosts at both time points ([Figure 1N](#fig1){ref-type="fig"}) (p\<0.0001, K-S test). Orientation of MZ*oep*^--/-- ^cellular protrusions was also partially improved within WT hosts ([Figure 1L--M](#fig1){ref-type="fig"}), as the distribution of these protrusions differed significantly from that in MZ*oep*^--/--^ controls but did not align to the same degree as in WT cells (p\<0.0001 and p=0.0053, respectively, Chi-square test). Together these results reveal an essential role for Nodal signaling in neuroectoderm C and E cell behaviors, including both non-autonomous and cell-autonomous functions during ML cell polarization.

![PCP signaling is active and contributes to C and E in Nodal signaling mutants.\
(**A**) Representative images of transplanted Prickle (Pk)-GFP donor cells (co-expressing H2B-RFP) within the neuroectoderm of membrane-labeled WT and MZ*oep*^--/--^ host gastrulae. Arrowheads indicate puncta at anterior edges. (**B**) Pk-GFP localization in the genotypes indicated. N indicates the number of embryos and cells analyzed for each condition from four independent trials, p\<0.001, Chi-square test. (**C**) Representative images of membrane-labeled MZ*oep*^--/--^ donor cells without (left) and with (right) 2 ng MO4-*vangl2* transplanted into the neuroectoderm of unlabeled host gastrulae from five independent trials. (**D**) Donor cell alignment as in [Figure 1](#fig1){ref-type="fig"}. The number of embryos in each condition is indicated on the corresponding panels in (**C**), WT→WT control N = 10. \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001; K-S tests. (**E**) Whole mount in situ hybridization (WISH) for *dlx3b* and *egr2b* in WT (top) and MZ*oep^--/^*^--^ (bottom) gastrulae at 9.5 hpf, uninjected or injected with 2 ng MO4-*vangl2*. Dorsal views on the left, lateral views on the right. (**F, G**) Width (**F**) and length (**G**) of neural plates in the embryos depicted in (**E**). Each dot represents a single embryo, black bars are mean values. Number of embryos in each condition is indicated on the corresponding panel in (**E**), p\<0.0001, Unpaired T-tests. Anterior is up in all images, scale bar is 20 μm in (**A**), 50 μm in (**C**), and 200 μm in (**E**).](elife-54445-fig2){#fig2}

Nodal functions partially in parallel with PCP signaling during axis extension {#s2-2}
------------------------------------------------------------------------------

The reduced ML polarity of MZ*oep^--/^*^--^neuroectoderm cells resembles PCP mutant phenotypes ([@bib34]; [@bib38]; [@bib73]; [@bib76]), raising the possibility that loss of PCP signaling may underlie C and E defects in MZ*oep* mutants. We compared gene expression in WT and MZ*oep*^--/--^ gastrulae at 90% epiboly (\~9 hpf) by RNA-sequencing and found that of the genes with known roles in PCP signaling in zebrafish, only one (*prickle1b*) exhibited altered expression in MZ*oep* mutants ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Accordingly, *wnt5b, vangl2* (*trilobite*), and *gpc4* (*knypek*) transcripts were all detected in MZ*oep*^--/--^ gastrulae by whole mount in situ hybridization (WISH) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Although this suggests that Nodal signaling does not regulate PCP at the level of gene expression, we hypothesized that it could instead regulate the activity of these signaling components. We therefore assessed PCP signaling activity by examining the intracellular localization of the core PCP component Prickle fused to GFP (Pk-GFP), whose association with anterior cell membranes is indicative of PCP activation and polarization ([@bib9]; [@bib90]), using transplantation to achieve sparse labeling of neuroectoderm cells. We found that WT cells (in WT hosts) and MZ*oep*^--/--^ cells (in MZ*oep*^--/--^ hosts) exhibited similar proportions of anteriorly localized Pk-GFP puncta, although MZ*oep* mutant cells contained significantly more membrane-associated puncta that were not anteriorly localized (chi-square, p=0.0001) ([Figure 2A, B](#fig2){ref-type="fig"}), suggesting that PCP signaling is largely active in Nodal signaling-deficient gastrulae.

Because PCP signaling establishes planar polarity via intra- and inter-cellular interactions between its molecular components ([@bib23]; [@bib4]), we hypothesized that the partial ML polarization of MZ*oep*^--/--^ cells observed upon transplantation into WT hosts indicates the ability of Nodal-deficient cells to respond to host PCP signaling ([Figure 1L, N](#fig1){ref-type="fig"}). To test this, we disrupted PCP signaling in MZ*oep*^--/--^ embryos using an antisense morpholino oligonucleotide (MO) against *vangl2* ([@bib86]) that phenocopies C and E defects of *trilobite/vangl2* mutants ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}; [@bib66]), and transplanted cells from these MZ*oep*^--/--^;*vangl2* morphant donors into the prospective neuroectoderm of WT hosts. At both mid- and late gastrulation stages, ML alignment was significantly reduced in MZ*oep*^--/--^;*vangl2* morphant cells compared with control MZ*oep^--/^*^--^cells ([Figure 2C, D](#fig2){ref-type="fig"}), further supporting the notion that PCP is active in the absence of Nodal signaling. Notably, in this series of experiments, we found that MZ*oep*^--/--^ donor cells were significantly less well aligned than WT control donors at both 8.5 and 10 hpf ([Figure 2D](#fig2){ref-type="fig"}). Together with the mosaic analyses described above and in [Figure 1K--N](#fig1){ref-type="fig"}, these results reveal a cell-autonomous role for Nodal in ML cell polarization throughout gastrulation. Finally, we tested whether disrupting PCP signaling using a *vangl2* MO reduced axis extension in MZ*oep* mutant gastrulae. We found that the neural plates of both WT and MZ*oep* mutants, as marked by expression of *dlx3b,* were significantly wider and shorter upon injection with *vangl2* MO than in uninjected controls at late gastrulation stages ([Figure 2E--G](#fig2){ref-type="fig"}), indicating reduced C and E. These results provide further evidence that PCP signaling is active and contributes to C and E movements in embryos lacking Nodal signaling. We noted that WISH staining for *dlx3b* was noticeably darker in MZ*oep*^--/--^gastrulae ([Figure 2E](#fig2){ref-type="fig"}), likely reflecting a slight increase in expression levels ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) compounded by increased cell density resulting from reduced extension of the neuroectoderm in these mutants ([Figure 1](#fig1){ref-type="fig"}; [@bib25]). Together, these results indicate that Nodal does not regulate C and E solely via PCP, and that PCP is not activated or polarized strictly downstream of Nodal.

Nodal signaling promotes ex vivo extension and tissue patterning {#s2-3}
----------------------------------------------------------------

We have demonstrated that Nodal signaling is necessary for full planar polarization of cells and cell behaviors underlying C and E gastrulation movements. To test whether Nodal is also sufficient for these behaviors, we sought to define the role of Nodal during axis extension in relative isolation, independent of other signaling and patterning events within the embryo. To this end, we employed blastoderm explantation, a technique that is used to excise only the animal-most region of the blastoderm from \~2.5 hpf zebrafish embryos, thereby isolating this region from endogenous signaling centers at the embryonic margin and producing clusters of relatively naïve cells that can be grown and manipulated in culture ([Figure 3A](#fig3){ref-type="fig"}; [@bib88]; [@bib56]; [@bib58]; [@bib75]). To determine the effect of Nodal signaling on such explants, we injected single-celled WT embryos with synthetic *ndr2* mRNA at doses from 2.5 to 100 pg per embryo, explanted the animal half of each blastoderm at the 256--512 cell stage (2.5 hpf), and cultured these explants ex vivo until intact siblings reached early segmentation stages ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We found that several of these doses induced robust extension of explants in culture, whereas explants cut from *GFP*-injected or uninjected WT control or from *ndr2*-injected MZ*oep*^--/--^ embryos failed to extend ([Figure 3B--E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

![Nodal ligands promote ex vivo C and E of blastoderm explants.\
(**A**) Diagram of injection and explantation of zebrafish embryos. (**B--E**) Representative bright-field images of live blastoderm explants of the indicated conditions/genotypes at the equivalent of the 2--4 somite stage. (**F**) Time-lapse DIC series of a representative explant from a WT embryo injected with 10 pg *ndr2* RNA. (**G, H**) Time-lapse series of H2B-RFP labeled nuclei (**G**) and automated cell tracking (**H**) within a representative explant from a WT embryo injected with 10 pg *ndr2* RNA. Tracks represent cell movements over 3.5 hr of time-lapse confocal imaging beginning at 7.5 hpf and are colored according to mean track displacement. (**I, J**) Displacement of cell tracks in the 'mediolateral' (**I**) and 'anteroposterior' (**J**) dimensions in explants from *ndr2*-injected (blue) and control *RFP*-injected (gray) WT embryos (as in [Figure 1](#fig1){ref-type="fig"}). Each dot represents a single cell track, each color represents an individual explant. N = 4 explants of each condition from two independent trials. (**K**) Absolute displacement of cell tracks in the ML and AP dimensions. (**L**) Representative images of WISH for the transcripts indicated in explants from WT embryos injected with 10 pg *ndr2* RNA. Scale bars are 200 μm.](elife-54445-fig3){#fig3}

Time-lapse imaging of live *ndr2*-injected explants revealed the onset of extension morphogenesis at or around 8 hpf ([Figure 3F](#fig3){ref-type="fig"}, [Video 2](#video2){ref-type="video"}), corresponding with the start of C and E movements in intact embryos ([@bib60]). All *ndr2* RNA doses induced some degree of extension over control explants, but the intermediate doses (5--25 pg) were most effective, with 10 pg producing the most extension and the highest dose tested (100 pg) producing the least ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Therefore, 10 pg *ndr2* was used for most subsequent experiments. Automated nuclear tracking within *ndr2*-expressing explants revealed patterns of cell movement that were characteristic of C and E by MIB ([Figure 3G--H](#fig3){ref-type="fig"}), with the axis of explant extension defined as 'AP' and the orthogonal axis as 'ML'. Indeed, plots of cell track displacement in the 'ML' and 'AP' dimensions ([Figure 3I--J](#fig3){ref-type="fig"}, blue) yielded the same negative and positive slopes, respectively, observed in intact embryos ([Figure 1](#fig1){ref-type="fig"}). These results demonstrate both convergence and extension movements within Nodal-expressing explants, although extension was more prominent ([Figure 3K](#fig3){ref-type="fig"}). Although cell movement was detected in *RFP*-injected control explants, cell track displacement was not spatially organized ([Figure 3I--J](#fig3){ref-type="fig"}, gray) and was significantly reduced compared to that in *ndr2*-expressing siblings ([Figure 3K](#fig3){ref-type="fig"}). We also examined cell divisions within *ndr2*-expressing explants to address the possibility that differential proliferation contributes to ex vivo extension. Although divisions were preferentially localized along the axis of extension, they were not concentrated in any particular region of the explant, and the number of cell divisions detected at these stages was relatively small ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). This suggests that, as in intact zebrafish gastrulae ([@bib43]), cell proliferation is not likely to be a major driver of C and E morphogenesis ex vivo, consistent with a recent report that blocking cell divisions in zebrafish blastoderm explants did not prevent their extension ([@bib58]).

###### Ex vivo extension of zebrafish blastoderm explants.

Time-lapse differential interference contrast (DIC) series from 7 hpf to 12.5 hpf of representative explants from an uninjected WT embryo (left) and a WT embryo injected with 10 pg *ndr2* RNA (right).

WISH assays revealed that explants expressed markers of endoderm, mesoderm (Spemann-Mangold organizer, axial and paraxial), and neuroectoderm according to the dose of *ndr2* with which they were injected, consistent with Nodal-dependent tissue induction in intact embryos ([@bib6]; [@bib71]; [@bib20]; [@bib57]). For example, low doses of *ndr2* induced robust expression of the neuroectoderm marker *sox2* and some paraxial mesoderm (*tbx16*), whereas high doses induced expression of the endoderm marker *sox17* and the organizer gene *gsc*, but less neuroectoderm ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). *GFP*- or un-injected control explants expressed none of these tissue-specific markers at appreciable levels. Notably, explants injected with 10 pg *ndr2* exhibited discrete gene expression domains: the mesoderm markers *tbxta*, *tbx16*, and *noto* were nearly always restricted to one end, *sox17* was present in small spots (likely to be individual endoderm cells), and *sox2* was observed in a striped pattern along the long axis of each explant ([Figure 3L](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Together, these results demonstrate that Nodal signaling specifies a number of tissue types in discrete, spatially organized domains and promotes C and E morphogenesis to varying degrees depending on ligand dose within isolated naïve blastoderm.

Blastoderm explants exhibit asymmetric Nodal signaling {#s2-4}
------------------------------------------------------

The gene expression patterns observed in *ndr2*-expressing explants revealed asymmetry along the axis of extension ([Figure 3L](#fig3){ref-type="fig"}), which is known to be critical for C and E morphogenesis of *Xenopus* explants ([@bib50]). To test whether graded Nodal signaling activity could account for this asymmetry, we immuno-stained *ndr2*-injected and uninjected WT control explants for phosphorylated Smad2, an indicator of active Nodal signaling ([Figure 4A](#fig4){ref-type="fig"}; [@bib67]). Using DAPI co-staining to create a nuclear mask, we used 3D automated object detection to quantify the location and pSmad2 staining intensity of all nuclei within each explant ([Figure 4A](#fig4){ref-type="fig"}, see \'Materials and methods\'). After filtering out nuclei below a threshold background staining level, we compared the spatial distribution of the resulting pSmad2-positive nuclei along the 'axis' of each explant ([Figure 4B--C](#fig4){ref-type="fig"}). Comparing pSmad2+ nuclei ([Figure 4B--C](#fig4){ref-type="fig"}, blue dots) to all nuclei (gray dots) revealed in *ndr2*-injected explants a significant asymmetry of their distribution, which began at 6 hpf and increased until 8 hpf (p\<0.0001, K-S tests), but very few pSmad2+ nuclei that exhibited little to no asymmetric distribution in uninjected controls ([Figure 4B, C](#fig4){ref-type="fig"}). Of note, the timing of pSmad2 detection differed between *ndr2*-injected explants and intact WT embryos, where an appreciable pSmad2 signal was detectable by 5 hpf ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), consistent with previous reports ([@bib77]; [@bib16]). pSmad2 then persisted in explants until at least 8 hpf, whereas no signal was detected after 6 hpf in embryos ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). No pSmad2 signal was detectable in embryos treated with the Nodal inhibitor SB-505124 ([@bib12]; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), indicating that this antibody specifically detected Nodal signaling activity. Further evidence of asymmetric Nodal signaling within explants was provided by increasing levels and asymmetry of *lefty1* (*lft1*) expression, a negative feedback inhibitor and direct transcriptional target of Nodal signaling ([@bib46]), in *ndr2*-expressing but not control explants ([Figure 4D](#fig4){ref-type="fig"}). These results demonstrate that injection of *ndr2* mRNA at the one-cell stage produces extending explants with asymmetric Nodal signaling activity.

![Nodal-expressing explants exhibit asymmetric Nodal signaling activity.\
(**A**) Representative confocal images of immunofluorescent staining for phosphorylated Smad2 and DAPI-labeled nuclei in 8hpf explants from WT embryos injected with 10 pg *ndr2*. DAPI z-stacks were used to create a three-dimensional mask from which nuclear pSmad intensities were detected and measured in an automated fashion. (**B, C**) Axis position of pSmad2-positive nuclei (blue) and all nuclei (gray) in explants from WT embryos injected with 10 pg *ndr2* (**B**) or uninjected (**C**) at the time points indicated. Each dot represents a single nucleus, pink bars are median values among pSmad2^+^ nuclei. N indicates the number of explants in each condition from five independent trials. Kolmogorov-Smirnov tests were used to compare the distribution of pSmad^+^ nuclei to all nuclei; \*\*\*\*, p\<0.0001; \*\*, p\<0.01. (**D**) Representative images of WISH for *lefty1* in uninjected (top) and *ndr2*-injected (bottom) explants fixed at the time points indicated. Scale bars are 100 μm.](elife-54445-fig4){#fig4}

Nodal signaling and PCP promote cell polarity underlying C and E ex vivo {#s2-5}
------------------------------------------------------------------------

*Xenopus* animal cap explants that are exposed to Activin signaling exhibit robust ML cell polarization and intercalation ([@bib50]; [@bib64]). To analyze planar cell polarity underlying Nodal-driven C and E in zebrafish explants, we quantified cell alignment using live fluorescent membrane labeling ([Figure 5](#fig5){ref-type="fig"}). At the equivalent of the 2--4S stage, when intact WT embryos exhibit strong ML cell alignment ([@bib61]), cells within *GFP*-expressing control explants were randomly oriented ([Figure 5A,C](#fig5){ref-type="fig"} median angle = 44°). This was in stark contrast to *ndr2*-expressing explants, whose extension was accompanied by robust ML alignment (defined as perpendicular to the axis of extension) of cells ([Figure 5A, C](#fig5){ref-type="fig"} median angle = 19°). This result demonstrates that Nodal signaling is sufficient to induce ML cell alignment underlying C and E morphogenesis in populations of otherwise naïve embryonic zebrafish cells.

![Disrupted PCP reduces Nodal-induced cell polarization and C and E within explants.\
(**A**) Representative confocal micrographs of live membrane-labeled explants of the indicated conditions at the equivalent of the 2--4 somite stage from two independent trials. (**B**) Representative bright-field images of blastoderm explants at 2--4S from four independent trials. (**C**) Explant cell alignment as in [Figure 1](#fig1){ref-type="fig"}. The number of explants in each condition is indicated on the corresponding panel in (**A**). Mediolateral (ML) is defined as orthogonal to the axis of extension. (**D, E**) Length/width ratios (**D**) and length (**E**) of explants depicted in (**B**). Each dot represents a single explant, black bars are median values. The number of explants in each condition is indicated on the corresponding panel in (**B**). p\<0.0001; Kruskal-Wallis test. Scale bar is 50 μm in (**A**), 200 μm in (**B**).](elife-54445-fig5){#fig5}

To ask whether Nodal-dependent ex vivo extension and ML cell alignment require PCP signaling, we generated explants from embryos that were co-injected with 10 pg *ndr2* mRNA and *vangl2* MO. *Vangl2* morphant explants exhibited overall lengths and length/width ratios that were significantly reduced compared with those in explants expressing *ndr2* alone, but significantly higher than those in uninjected controls ([Figure 5B, D, E](#fig5){ref-type="fig"}). It was recently reported that zebrafish blastoderm explants from embryos mutant for the PCP components *wnt11*, *wnt5b*, and *fzd7a/b* exhibited a similar reduction in ex vivo extension ([@bib58]). Live imaging of fluorescently labeled cell membranes further revealed that ML cell alignment was reduced but not entirely randomized in *vangl2* morphant explants compared with explants expressing *ndr2* alone ([Figure 5A, C](#fig5){ref-type="fig"} median angle = 26°). Because Nodal is necessary and sufficient for ML cell polarization ex vivo, and this polarity is reduced upon disruption of PCP signaling, these results indicate that PCP signaling functions downstream of Nodal in explant extension.

Nodal signaling promotes ex vivo C and E independent of mesoderm {#s2-6}
----------------------------------------------------------------

The requirement for Nodal signaling in zebrafish axis extension is well-described, but evidence suggests that this role is secondary to the ability of Nodal to specify mesoderm ([@bib1]; [@bib22]; [@bib2]; [@bib65]). However, the presence of mesoderm in the absence of Nodal is not sufficient for C and E to occur ([@bib50]; [@bib31]), and loss of a subset of *Xenopus* Nodal ligands disrupts C and E without affecting mesoderm formation ([@bib44]), indicating a possible primary role for Nodal in extension morphogenesis. This is consistent with our results showing that polarity of MZ*oep*^--/--^ donor cells is only partially restored by transplantation into WT hosts ([Figure 1](#fig1){ref-type="fig"}), which both corroborate the importance of mesoderm for proper C and E and suggest an additional cell-autonomous role for Nodal signaling in C and E cell behaviors. To determine whether Nodal plays a mesoderm-independent role in ex vivo C and E, we used SB-505124 (SB) to disrupt Nodal signaling within *ndr2*-expressing explants after mesoderm was specified ([Figure 6A](#fig6){ref-type="fig"}). Addition of 50 μM SB at 4, 5, or 6 hpf completely blocked both explant extension and expression of the mesoderm markers (and direct transcriptional targets of Nodal signaling; [@bib16]) *tbxta* and *noto* at 2--4S stage ([Figure 6B--C](#fig6){ref-type="fig"}). By contrast, treatment of intact WT embryos with SB did not prevent AP axis extension after 5 hpf ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), consistent with previous reports ([@bib28]). Critically, explants treated with SB at 8 hpf underwent extension but were significantly shorter than DMSO-treated controls despite robust mesoderm marker expression ([Figure 6B, C](#fig6){ref-type="fig"}) (p\<0.0001, Mann-Whitney test), indicating that Nodal contributes to ex vivo C and E after mesoderm formation.

![Nodal promotes ex vivo C and E independent of mesoderm.\
(**A**) Diagram of the time course of SB-505124 (SB) treatment of *ndr2*-expressing explants. (**B**) Representative images of WISH for the transcripts indicated in explants from WT embryos injected with 10 pg *ndr2* RNA, treated with SB at the indicated time points, and fixed at the equivalent of the 2--4 somite stage from four independent trials. (**C**) Length/width ratios of explants shown in (**B**). Each dot represents a single explant, black bars are median values; p\<0.0001, Mann-Whitney test. (**D**) Diagram of the time course of SB treatment of *ndr2*-expressing explants followed by washout. (**E**) Representative images of WISH for the indicated transcripts in explants from WT embryos injected with 10 pg *ndr2* RNA, treated with SB at the indicated time points, and fixed at the equivalent of the 2--4 somite stage from four independent trials. (**F**) Length/width ratios of explants shown in (**E**), as in panel (**C**). \*\*\*\*p\<0.0001, Mann-Whitney test. Scale bars are 300 μm.](elife-54445-fig6){#fig6}

We next sought to evaluate the role of Nodal signaling in the absence of mesoderm by disrupting mesoderm formation in *ndr2*-expressing explants with a discrete two-hour pulse of SB, then allowing Nodal signaling to resume upon wash-out of the inhibitor ([Figure 6D](#fig6){ref-type="fig"}). Treatment from 4 hpf to 6 hpf completely blocked mesoderm marker expression and extension, even after the inhibitor was removed ([Figure 6E, F](#fig6){ref-type="fig"}). Treatment from 6 hpf to 8 hpf similarly blocked expression of the mesoderm markers *tbxta, noto*, and *tbx16*, but dramatically increased expression of the neuroectoderm markers *sox2* and *otx2b* by WISH ([Figure 6E](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Moreover, these neural-only explants exhibited marked (albeit reduced compared with DMSO controls) extension ([Figure 6E, F](#fig6){ref-type="fig"}), demonstrating that Nodal signaling promotes ex vivo neuroectoderm C and E even in the absence of mesoderm. Because sustained SB treatment beginning at 6 hpf completely blocked explant extension ([Figure 6B--C](#fig6){ref-type="fig"}), this extension must be driven by Nodal signaling after removal of the inhibitor at 8 hpf. Indeed, inhibiting only this later phase of signaling by SB treatment at 8 hpf prevented full explant extension even in the presence of mesoderm ([Figure 6C, F](#fig6){ref-type="fig"}), indicating that Nodal signaling after C and E onset contributes significantly to ex vivo extension morphogenesis. These results support a tissue-autonomous requirement for Nodal signaling in ex vivo neuroectoderm C and E that is distinct from its role in mesoderm formation.

Discussion {#s3}
==========

Coordination of embryonic patterning and morphogenesis is among the most fundamental and least understood problems in developmental biology. AP axial patterning is necessary for the evolutionarily conserved gastrulation movements of C and E within *Drosophila* ([@bib32]; [@bib51]) and vertebrate embryos ([@bib50]), but how C and E movements are coordinated with embryonic patterning in vertebrates is only beginning to be understood. The noncanonical Wnt/PCP signaling network is thought to act as a molecular compass that recognizes anterior and posterior cell edges in order to mediate ML cell polarization ([@bib24]). Although exogenous Wnt ligands were shown to reorient PCP components and planar cell polarity in zebrafish and *Xenopus* gastrulae ([@bib42]; [@bib8]), it is unclear whether endogenous Wnt ligands, either exclusively or in cooperation with additional signals, orient the PCP compass in vivo. Additional mechanical cues such as tension at tissue boundaries and directional strain also regulate planar cell polarity ([@bib7]; [@bib87]), but how such cues are linked to axial patterning is not well understood. Here, using a combination of intact zebrafish gastrulae and an ex vivo model of axial extension, we have defined critical roles for the morphogen Nodal in regulating cell behaviors underlying C and E of the primary embryonic axis. Our findings support a model in which Nodal signaling promotes C and E cell behaviors both upstream of and in parallel with PCP signaling, while additional Nodal-independent mechanisms --- likely AP patterning cues --- polarize PCP signaling ([Figure 7](#fig7){ref-type="fig"}).

![A model for the roles of PCP and Nodal signaling in C and E gastrulation movements.\
In intact embryos (left), Nodal signaling acts largely in parallel with PCP signaling to regulate the ML cell polarization that underlies C and E. PCP signaling activity and localization of its components are regulated by an additional unknown signal(s) (X), and maintains residual polarizing activity in the absence of Nodal. In embryonic explants (right), PCP signaling activity and C and E cell behaviors are regulated wholly downstream of Nodal signaling.](elife-54445-fig7){#fig7}

Because Nodal signaling is necessary for both AP axial patterning ([@bib6]; [@bib71]; [@bib20]) and polarized C and E cell behaviors (this work), it is a prime candidate to act upstream of PCP to orient the compass, thereby coordinating axial patterning and morphogenesis. Indeed, we found that impaired C and E in the neuroectoderm of Nodal signaling-deficient gastrulae was associated with reduced ML cell polarization ([Figure 1](#fig1){ref-type="fig"}), a phenotype also observed in PCP mutants ([@bib34]; [@bib38]; [@bib73]; [@bib76]). We further found, as others have observed for Activin and Nodal ([@bib50]; [@bib64]; [@bib88]), that Nodal can induce both ML cell polarity and C and E in naïve explants ([Figure 3](#fig3){ref-type="fig"}). Moreover, this ex vivo Nodal-induced C and E is strongly reduced when PCP signaling is disrupted ([Figure 5](#fig5){ref-type="fig"}), indicating that Nodal functions upstream of PCP signaling. However, additional in vivo evidence suggests a more complex interaction between these two signaling systems. We found that within Nodal-deficient MZ*oep* mutant gastrulae, transcripts encoding PCP signaling components were expressed at largely normal levels ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and the asymmetric intracellular localization of the core PCP component Prickle-GFP was only mildly affected ([Figure 2](#fig2){ref-type="fig"}). Finally, defects in C and E cell behaviors and axis extension, resulting from complete loss of Nodal signaling, were exacerbated by disrupted PCP signaling ([Figure 2](#fig2){ref-type="fig"}), providing additional evidence that PCP signaling remains active in the absence of Nodal. On the basis of these lines of evidence, we posit that Nodal is not absolutely required for the asymmetric distribution of this core PCP component nor for the transcriptional regulation of PCP genes in vivo, and plays only a minor role in regulating PCP signaling in intact embryos. Importantly, this indicates that Nodal is required for polarized C and E cell behaviors *in addition to* intact PCP signaling, rather than acting strictly upstream. Taken together, these data demonstrate that PCP and Nodal are each necessary -- but not sufficient -- for full ML polarization of cell behaviors underlying C and E, suggesting that Nodal functions largely in parallel with PCP in vivo ([Figure 7](#fig7){ref-type="fig"}). They also suggest that an additional signal (or signals) beyond Nodal instructs PCP signaling and the asymmetry of its components within the gastrula ('X' in [Figure 7](#fig7){ref-type="fig"}).

Results from explant experiments lead us to refined conclusions regarding the relationship between Nodal and PCP. Because 1) no cell polarity or C and E is observed in the absence of Nodal signaling in naïve blastoderm explants, 2) expression of Nodal ligands is sufficient to induce PCP-dependent ML cell polarization and C and E in the absence of other apparent patterning cues ([Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}), and 3) this Nodal-induced ML cell polarization is strongly reduced by interference with PCP signaling ([Figure 5](#fig5){ref-type="fig"}), we interpret these results as indicating that PCP functions wholly downstream of Nodal in this ex vivo context ([Figure 7](#fig7){ref-type="fig"}). Although we cannot rule out the possibility that an additional non-Nodal signal regulates PCP in explants ('X'), any such signal would also operate downstream of Nodal. It is also possible that 'X' functions strictly in parallel with Nodal in vivo, and that this signal is absent from the explant system.

C and E and cell polarization were reduced but not completely abolished in *ndr2*-expressing *vangl2* morphant explants ([Figure 5](#fig5){ref-type="fig"}), as is observed in intact *trilobite/vangl2* mutant embryos ([@bib34]). This may indicate that Nodal contributes to polarized cell behaviors ex vivo through an additional PCP-independent mechanism ('Y' in [Figure 7](#fig7){ref-type="fig"}), that knockdown of *vangl2* alone does not completely abolish PCP signaling, or a combination of both. Indeed, accumulating evidence suggests that PCP is a complex signaling network comprised of multiple functionally discrete modules, such that loss of one may not entirely disrupt PCP as a whole ([@bib24]). For example, *vangl2* and *gpc4* compound zebrafish mutants have an additive C and E phenotype, implying that these two PCP components do not work in a simple linear pathway ([@bib45]). *scribble* and *vangl2* were also recently reported to function in parallel with non-canonical Wnt ligands to align hair cells in zebrafish ([@bib49]), reinforcing the notion of multiple modules under the larger PCP umbrella. This complexity raises the possibility that Nodal signaling regulates only a subset of PCP signaling modules. For instance, although Nodal is not strictly required for asymmetric localization of Pk-GFP or Vangl2-dependent cell polarity in vivo ([Figure 2](#fig2){ref-type="fig"}), it may regulate the localization/activity of other PCP modules or PCP-associated molecules.

The results reported here are consistent with, but expand significantly upon, previous models for the role of Nodal in gastrulation morphogenesis. [@bib50] proposed that AP patterning by Nodal-related signals is required to orient the polarity of PCP signaling during C and E gastrulation movements. Although we similarly found that Nodal signaling is sufficient to induce both asymmetric patterning and PCP-dependent C and E, our genetic analyses indicate that Nodal is not strictly required for PCP polarization in vivo, and that the role of Nodal in C and E is not limited to AP patterning. Furthermore, although we observed asymmetric Nodal signaling in extending explants ([Figure 4](#fig4){ref-type="fig"}), it is not yet clear that this asymmetry is required for C and E cell behaviors. The source of this asymmetry is also unclear because the embryos were injected with *ndr2* RNA at the single-cell stage. We speculate that feed-back and feed-forward signaling mechanisms ([@bib48]) may act to amplify small (and unavoidable) asymmetries in the distribution of injected RNAs. The importance of Nodal in axis extension has also been attributed to its ability to specify mesoderm ([@bib1]; [@bib22]; [@bib2]), implying that Nodal-dependent mesoderm is required for C and E rather than Nodal signaling per se. We demonstrate here that Nodal contributes to ex vivo extension after mesoderm is specified and even in the absence of mesoderm ([Figure 6](#fig6){ref-type="fig"}), arguing for a primary, mesoderm-independent role for Nodal in C and E in addition to its well-described mesoderm-dependent functions. Transcriptional targets of Nodal signaling that regulate C and E independently of either PCP or mesoderm formation ('Y' in [Figure 7](#fig7){ref-type="fig"}) remain largely unknown, and identification of these molecules will be an important goal for future studies.

The blastoderm explants described in this study provide a robust, simplified model of axial extension in which a signaling molecule of interest --- in this case, Nodal --- can be studied independently of endogenous patterning and signaling events. It has been shown that some methods of zebrafish blastoderm explantation do not require the addition of Nodal or any other signaling molecules to induce extension ([@bib58]; [@bib75]), but these explants are generated from the entire blastoderm and therefore contain signals (Nodal and otherwise) already present at the embryonic margin ([@bib18]). By contrast, unmanipulated explants containing only the animal-most blastoderm are comparatively naïve, as they exclude endogenous signals from the margin, and fail to extend ([@bib88]; [@bib56]; [@bib58]; [@bib75] \[this work\]), similar to classic *Xenopus* animal cap explants ([@bib31]). Although explants from any species are a powerful tool, we must acknowledge ways in which this system differs from intact embryos. Namely, because explants do not contain the full complement of molecular signals and tissue interactions present in intact embryos, the contribution of additional signals to C and E may be masked by the reliance of explant extension on Nodal alone. This is illustrated by the function of PCP both downstream of and in parallel with Nodal in vivo, but strictly downstream of Nodal ex vivo ([Figure 7](#fig7){ref-type="fig"}). The absence of a yolk cell also dramatically alters the geometry of explanted tissues and removes signaling input from the extraembryonic yolk syncytial layer ([@bib58]). Despite these differences, explants exhibit a suite of complex, biologically relevant behaviors in common with intact embryos, including C and E morphogenetic movements, ML cell polarization, timing of C and E onset, and transcriptional responses to Nodal. These explants therefore provide a simplified platform that has allowed for new insights into the role of Nodal signaling in C and E morphogenesis and for dissection of its complex relationship with PCP. Although Nodal signaling functions wholly upstream of PCP-dependent ML planar polarity of cells ex vivo, in vivo it functions in an overlapping fashion and cooperates with PCP signaling, whose activity is regulated by additional, as yet unidentified, signaling events ([Figure 7](#fig7){ref-type="fig"}).

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                               Designation                               Source or\                         Identifiers                                                                                Additional\
  (species) or resource                                                                 reference                                                                                                                     information
  ------------------------------------------- ----------------------------------------- ---------------------------------- ------------------------------------------------------------------------------------------ -------------------------------------
  Gene (*Danio rerio*)                        *tdgf1* (*oep*)                           ZFIN                               RRID:[ZFIN_ZDB-GENE-990415-198](https://scicrunch.org/resolver/ZFIN_ZDB-GENE-990415-198)   

  Gene (*Danio rerio*)                        *ndr2* (*cyc*)                            ZFIN                               RRID:[ZFIN_ZDB-GENE-990415-181](https://scicrunch.org/resolver/ZFIN_ZDB-GENE-990415-181)   

  Strain, strain background (*Danio rerio*)   AB\*                                      ZIRC                               RRID:[ZFIN_ZDB-GENO-960809-7](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-960809-7)       

  Genetic reagent (*Danio rerio*)             *oep^tz257^*                              [@bib29]                           RRID:[ZFIN_ZDB-GENO-130130-2](https://scicrunch.org/resolver/ZFIN_ZDB-GENO-130130-2)       Point mutation

  Recombinant DNA reagent                     pJZoepFlag1-2 in pcDNA3\                  [@bib93]                                                                                                                      Template for in vitro transcription
                                              (plasmid)                                                                                                                                                               

  Recombinant DNA reagent                     *ndr2* in PCS2+\                          [@bib57]                                                                                                                      Template for in vitro transcription
                                              (plasmid)                                                                                                                                                               

  Recombinant DNA reagent                     *membrane Cherry* in PCS2+\               Gift from Dr Fang Lin                                                                                                         Template for in vitro transcription
                                              (plasmid)                                                                                                                                                               

  Recombinant DNA reagent                     *membrane eGFP* in PCS2+\                 [@bib81]                                                                                                                      Template for in vitro transcription
                                              (plasmid)                                                                                                                                                               

  Recombinant DNA reagent                     *H2B-RFP* in PCS2 (plasmid)               Gift from Dr John Wallingford                                                                                                 Template forin vitro transcription

  Recombinant DNA reagent                     *Drosophila* Prickle-GFP\                 [@bib33]                                                                                                                      Template for in vitro transcription
                                              (*plasmid*)                                                                                                                                                             

  Antibody                                    Anti-phospho Smad2/3                      Cell Signaling Technology \#8828   RRID:[AB_2631089](https://scicrunch.org/resolver/AB_2631089)                               IF (1:1000)

  Antibody                                    Invitrogen\                               Thermo Fisher\                     RRID:[AB_143165](https://scicrunch.org/resolver/AB_143165)                                 IF (1:1000)
                                              AlexaFluor 488 goat anti-rabbit IgG       \#A-11008                                                                                                                     

  Antibody                                    Roche Anti-digoxigenin-AP Fab fragments   Millipore Sigma\                   RRID:[AB_2734716](https://scicrunch.org/resolver/AB_2734716)                               1:5000
                                                                                        \#11093274910                                                                                                                 

  Commercial assay or kit                     Roche Digoxigenin RNA labelling mix       Millipore Sigma\                                                                                                              
                                                                                        \#11277073910                                                                                                                 

  Other                                       Roche BM Purple AP staining solution      Millipore Sigma\                                                                                                              
                                                                                        \#11442074001                                                                                                                 

  Sequenced-based reagent                     MO4-*vangl2*\                             GeneTools\                                                                                                                    AGTTCCACCTTACTCCTGAGAGAAT
                                              Morpholino antisense oligonucleotide      ([@bib86])                                                                                                                    

  Commercial assay or kit                     Invitrogen mMessage mMachine SP6 kit      Thermo Fisher\                                                                                                                
                                                                                        \# AM1340                                                                                                                     

  Commercial assay or kit                     RNeasy Mini kit                           Qiagen\                                                                                                                       
                                                                                        \#74104                                                                                                                       

  Chemical compound, drug                     Ambion\                                   Thermo Fisher\                                                                                                                
                                              Trizol reagent                            \#15596018                                                                                                                    

  Chemical compound, drug                     SB-505124                                 Millipore Sigma\                                                                                                              50 mM
                                                                                        \# S4696                                                                                                                      

  Peptide, recombinant protein                Roche Pronase                             Millipore Sigma\                                                                                                              
                                                                                        \#10165921001                                                                                                                 

  Other                                       New-born calf serum                       Invitrogen\                                                                                                                   
                                                                                        \#26010--066                                                                                                                  

  Software, algorithm                         Imaris                                    Oxford Instruments                 RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370)                               Live cell tracking

  Software, algorithm                         ImageJ/FIJI                               ImageJ/FIJI                        RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)                               Image analysis

  Software, algorithm                         Prism 8                                   Graphpad                           RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)                               Statistics and graphs
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Zebrafish {#s4-1}
---------

Adult zebrafish were raised and maintained according to established methods ([@bib85]) in compliance with standards established by the Washington University Institutional Animal Care and Use Committee. Embryos were obtained from natural matings and staged according to morphology as described ([@bib39]). All studies on WT embryos were carried out in AB\* backgrounds. Additional lines used include *oep^tz257^* ([@bib29]) on AB\* background. *oep*^--/--^ embryos were rescued by injection of 50 pg synthetic *oep* RNA ([@bib93]) and raised to adulthood, then intercrossed to generate maternal-zygotic *oep^--/^*^--^embryos. Fish were chosen from their home tank to be crossed at random, and the resulting embryos were also chosen from the dish at random for injection and inclusion in experiments.

Microinjection of synthetic RNA and morpholino oligonucleotides {#s4-2}
---------------------------------------------------------------

Single-celled embryos were aligned within agarose troughs made from custom plastic molds and injected with 1--3 nL volumes using pulled glass needles. Synthetic mRNAs for injection were made by in vitro transcription from linearized plasmid DNA templates using Invitrogen mMessage mMachine kits. Doses of RNA per embryo were as follows: 100 pg *membrane Cherry* (a kind gift from Dr Fang Lin), 50 pg membrane *eGFP* ([@bib81]), 25 pg *H2B-RFP* (a kind gift from Dr. John Wallingford), 50 pg *Drosophila pk-gfp* ([@bib33]), and 2.5--100 pg *ndr2* ([@bib57]). Injection of 2 ng MO4-*tri/vangl2* ([@bib86]) was carried out as for synthetic RNA.

Pharmacological treatments {#s4-3}
--------------------------

50 μM SB-505124 (Sigma \#S4696) was added to the media of embryos and explants in agarose-coated 6-well plates at the times specified. For wash-out experiments, SB-containing medium was removed and explants were washed twice with 0.3x Danieau solution, before fresh explant medium was introduced.

Immunofluorescent staining {#s4-4}
--------------------------

Embryos and explants were stained for phosphorylated Smad2 as described in [@bib77]. Briefly, samples were fixed overnight in 4% paraformaldehyde (PFA), rinsed in phosphate-buffered saline (PBS) + 0.1% Tween-20 (PBT), and dehydrated to 100% methanol. Prior to staining, samples were rehydrated into PBS, rinsed in PBS + 1% Triton X-100, and incubated in ice-cold acetone at −20°C for 20 min. Samples were then blocked in PBS+ 10% FBS and 1% Triton X-100, and then incubated overnight at 4°C with an anti-pSmad2/3 antibody (Cell Signaling \#8828) at 1:1000 in block. Samples were rinsed in PBT/1% Triton X-100 and incubated with Alexa Fluor 488 anti-Rabbit IgG (Invitrogen) at 1:1000. Embryos were co-stained with 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) and rinsed in PBS + 1% Triton X-100 prior to mounting in 2% methylcellulose for confocal imaging.

Whole mount in situ hybridization {#s4-5}
---------------------------------

Antisense riboprobes were transcribed using NEB T7 or T3 RNA polymerase and labeled with digoxygenin (DIG) (Roche). Whole-mount in situ hybridization (WISH) was performed according to [@bib72]. Briefly, embryos and explants were fixed overnight in 4% PFA in PBS, rinsed in PBT, and dehydrated into methanol. Samples were then rehydrated into PBT, incubated for at least two hours in hybridization solution with 50% formamide (in 0.75 M sodium chloride, 75 mM sodium citrate, 0.1% tween 20, 50 μg/mL heparin (Sigma), and 200 μg/mL tRNA) at 70°C, then hybridized overnight at 70°C with antisense probes diluted approximately 1 ng/μL in hybridization solution. Samples were washed gradually into 2X SSC buffer (0.3 M sodium chloride, 30 mM sodium citrate), and then gradually from SSC to PBT. Samples were blocked at room temperature for several hours in PBT with 2% goat serum and 2 mg/mL bovine serum albumin (BSA), then incubated overnight at 4°C with anti-DIG antibody (Roche \#11093274910) at 1:5000 in block. Samples were rinsed extensively in PBT, and then in staining buffer (PBT +100 mM Tris \[pH 9.5\], 50 mM MgCl~2~, and 100 mM NaCl) prior to staining with BM Purple AP staining solution (Roche).

RNA-sequencing {#s4-6}
--------------

RNA for sequencing was isolated from 50 pooled WT or MZ*oep*^--/--^ embryos at the 90% epiboly stage from three independent clutches per genotype (three biological replicates). Embryos were lysed and total RNA was isolated using Trizol reagent (Ambion), then cleaned up using a Qiagen RNeasy kit. Samples were submitted to the Washington University Genome Technology Access Center for library preparation, including depletion of ribosomal RNA. Libraries were sequenced using an Illumina HiSeq3000 to obtain single-ended 50-bp reads. Raw reads were trimmed with cutadapt to remove low-quality bases and aligned to *Danio rerio* genome GRCz10 using STAR_2.5.4b ([@bib14]) with Ensembl v83 annotation. Aligned reads were quantified using featureCounts 1.6.3 from the subreads package ([@bib41]).

Blastoderm explants {#s4-7}
-------------------

Embryos were injected with *ndr2*, *H2B-RFP,* and/or *membrane GFP* RNA (and MOs) at the one-cell stage as described above, or left uninjected, then dechorionated using Pronase (Roche). At the 256--512 cell stage, watchmaker's forceps were used to excise the animal portion of each embryo in an agarose-coated dish filled with 3X Danieau solution, cutting the blastoderm at approximately 50% of its height and collecting the animal-most \~1/3 of cells from each embryo, as described in [@bib88]. Explants were allowed to heal briefly, then transferred into agarose-coated 6-well plates containing explant medium --- comprised of Dulbecco's modified eagle medium with nutrient mixture F-12 (Gibco 11330032) containing 2.5 mM L-glutamine, 15 mM HEPES, 3% newborn calf serum (Invitrogen 26010--066), 50 units/mL penicillin, and 50 μg/mL streptomycin (10,000 U/mL pen-strep at 1:200, Gibco 15140163) --- and incubated at 28.5°C until the desired stage.

Transplantation {#s4-8}
---------------

For cell autonomy and Pk-GFP transplants, host and donor embryos were injected with RNA encoding fluorescent nuclear and membrane markers, MOs, and/or Pk-GFP as described above. For cell autonomy, donor embryos were injected with *membrane Cherry* or *membrane GFP* and cells were transplanted into unlabeled hosts. For Pk-GFP localization, donor embryos were co-injected with *mCherry*, *prickle-GFP,* and *H2B-RFP* RNA and cells were transplanted into *mCherry*-injected hosts. Hosts and donors were dechorionated using Pronase, then arranged within the wells of a custom-molded agarose plate at approximately sphere stage. Approximately 20--40 cells were transferred from donors to hosts using a fine-pulled glass capillary.

Microscopy {#s4-9}
----------

Live embryos/explants expressing fluorescent proteins were mounted in 0.75% low-melt agarose, and fixed embryos/explants subjected to immunofluorescent staining were mounted in 2% methylcellulose in glass- bottomed 35 mm Petri dishes for imaging using a modified Olympus IX81 inverted spinning disc confocal microscope equipped with Voltran and Cobolt steady-state lasers and a Hamamatsu ImagEM EM CCD digital camera. For live time-lapse series, 60--100 μm z-stacks with a 1--2 μm step were collected every 3--5 minutes (depending on the experiment) for 3 hours using a 20x or 40x dry objective lens for intact embryos and a 20x objective for explants. Temperature was maintained at 28.5°C during imaging using a Live Cell Instrument stage heater. For immuno-stained embryos and explants, 100 μm z-stacks with a 1 or 2 μm step were collected using a 10x or 20x dry objective lens, depending on the experiment. Bright-field and transmitted light images of live embryos and in situ hybridizations were collected using a Nikon AZ100 macroscope.

Image analysis {#s4-10}
--------------

ImageJ was used to visualize and manipulate all microscopy data sets.

### Individual cell measurements {#s4-10-1}

Within live embryos and explants expressing either membrane eGFP or membrane Cherry, a single z-plane (in ubiquitously labeled embryos) or a projection of several z-planes (when measuring transplanted cells) through the neuroectoderm was chosen for each time point. To measure cell orientation and elongation, the AP axis in all embryo images was aligned prior to manual outlining of cells. A fit ellipse was used to measure the orientation of each cell's major axis and its aspect ratio. To assess Pk-GFP localization, isolated donor cells co-expressing Pk-GFP and H2B-RFP were scored according to the subcellular localization of GFP signal. Cell protrusions were manually detected within time-lapse stacks of transplanted neuroectoderm cells and their orientation measured in ImageJ. These orientations were binned into one of 12 sectors (30° each), which were categorized as mediolateral (within 60° of horizontal), anteroposterior (within 60° of vertical), or neither (the remaining 120°). The distribution of protrusions within each of these categories was then compared between experimental conditions using Chi-square tests.

### Automated nuclear tracking {#s4-10-2}

Imaris software and the ImageJ TrackMate plugin were used to detect and track labeled nuclei automatically in the dorsal hemisphere of WT and MZ*oep* mutant gastrulae and in embryonic explants injected with RNA encoding H2B-RFP, and to produce color-coded depictions of their trajectories and measurements of speed and displacement. Track displacement in the X (mediolateral) and Y (anteroposterior) dimensions were calculated independently, and plotted against their starting positions within the embryo/explant using Graphpad Prism 8 software. Cell divisions were manually detected within time-lapse stacks of explants from WT embryos co-injected with *H2B-RFP* and *ndr2* RNA, and their locations with respect to the center of each explant were measured using ImageJ.

### Morphometric measurements {#s4-10-3}

To measure the length/width ratios of explants, we divided the length of a segmented line drawn along the midline of each explant (accounting for curvature) by the length of a perpendicular line spanning the width of the explant near its midpoint. To measure width of the neural plate in whole-mount embryos, dorsal-view images were collected of each embryo, and a line was drawn from one side of the *dlx3b* expression domain to the other side at the level of the future mid-hindbrain boundary marked by *egr2b* expression. Length measurements were made similarly by measuring from the anterior to posterior aspects of the *dlx3b* expression domain in lateral-view images. Images were coded and analyses were performed blinded to ensure unbiased measurements.

### pSmad2 immunostaining in explants {#s4-10-4}

DAPI z-stacks were converted into 3D masks, which were used to create z-stacks of nuclear pSmad2 labeling. All stacks were oriented such that the highest apparent pSmad2 signal (if any) was to the left, and the ImageJ '3D Objects counter' plugin was used to detect the location and pSmad2 fluorescence intensity of all nuclei in a given explant. All nuclei with fluorescence intensities above a threshold background level were categorized as pSmad2-positive.

Statistical analysis {#s4-11}
--------------------

Graphpad Prism 8 software was used to perform statistical analyses and to generate graphs of data collected from embryo and explant images. The statistical tests used varied as was appropriate for each experiment and are described in the text and figure legends. Data were tested for normal distribution, and non-parametric tests (Mann-Whitney and Kolmogorov-Smirnov) were used for all non-normally distributed data. Normally distributed data with similar variance between groups were analyzed using parametric tests (T-tests). All tests used were two-tailed. Circular histograms were created using PAST software.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The formation of the vertebrate anterior-posterior axis has long been known to depend on two major signaling pathways: Nodal controls tissue specification, whereas Planar Cell Polarity (PCP) signaling controls morphogenesis by regulating cell movements that elongate the anterior-posterior axis through convergent extension. This paper now provides strong evidence that both Nodal and PCP signaling participate in convergent extension. The authors found that Nodal signaling is necessary and sufficient to drive axis extension in zebrafish embryos and naive cell clumps, likely independently of its role in tissue specification. Together, these results support a revised model for the role of Nodal signaling in anterior-posterior axis formation.

**Decision letter after peer review:**

Thank you for submitting your article \"Nodal and Planar Cell Polarity signaling cooperate to regulate zebrafish convergence & extension gastrulation movements\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript, Williams and Solnica-Krezel propose that Nodal and PCP signaling cooperate to regulate convergence and extension (CE) movements during zebrafish axis formation. The authors nicely show that the absence of Nodal signaling impairs extension and, to a lesser degree, also convergence movements of ectoderm. Moreover, they show that the cell alignments defects in Nodal signaling-deficient embryos are worsened by impaired PCP signaling. Similarly, the extension of blastoderm explants depends on the right dosage of Nodal signaling and is impaired in PCP signaling-deficient explants. The authors suggest that these results indicate that Nodal works both in parallel and upstream of PCP signaling in vivo. However, more evidence is needed to substantiate these claims.

Essential revisions:

1\) The fact that the MZoep phenotype is worsened by the absence of Vangl2 indicates that both pathways are needed for ectoderm CE. Yet, it is not clear to what extent Nodal might also function upstream of PCP signaling. Especially, the evidence that PCP signaling is partially disrupted in MZoep mutants is not entirely convincing. To strengthen this conclusion, it would be good to test, for instance, (i) to what extent the MZoep CE phenotype can be rescued by PCP activation, and (ii) which aspect of PCP signaling (dynamic subcellular localization, expression level, turnover etc.) might partially depend on Nodal signaling.

2\) If CE is affected by loss of Nodal activity, a widening of the neural plate would be expected similar to the findings for the *vangl2* MO. However, MZ*oep* embryos actually have narrower neural plates than WT (Figure 2E, F), undermining the proposal that Nodal regulates CE. Also, why are the markers in Figure 2E more intensely stained in MZ*oep* embryos compared to WT?

3\) The statement \"Orientation of MZ*oep*-/- cellular protrusions was also only partially improved within WT hosts (Figure 1I)\" is not supported and should be adjusted, since the graphs in Figure 1H and I look similar. The finding that MZ*oep* cells transplanted into wildtype hosts display nearly normal protrusion orientation is interesting. Does this depend on the polarization of the surrounding cells and would, for instance, wildtype ectoderm cells have a more random orientation of the protrusions when transplanted into MZ*oep*?

4\) Using the blastoderm explants, the authors suggest that convergence movements in this ex vivo system depend on Nodal signaling and that Nodal acts upstream of PCP signaling. However, the extension of the explant or the alignments of the cells aren\'t necessarily a readout of convergence movements. To claim this, it would be necessary to show actual convergence movements of the cells. Is it possible that elongation is promoted by a general increase in cell movements or differential proliferation? Is Prickle-GFP localization polarized in explants? Furthermore, injection of Nodal ligands also induces the specification of endoderm and mesoderm, which are both lacking in the uninjected control. The activation of PCP signaling during the extension of the explant could be due to the presence of endoderm and mesoderm rather than due to the activity of Nodal signaling per se. Drug treatment to block Nodal signaling after acquisition of cell fate could be a possible experiment to discriminate whether continuous Nodal signaling activity is needed. The paper would also benefit from a clearer distinction between elongation and CE. This is crucial since the effect of Nodal could in principle be mostly on prechordal plate migration rather than CE.

5\) Nodal acts highly locally, not in a widespread manner throughout the embryo (see Figure 4---figure supplement 1 and Xu et al., 2014). How would Nodal regulate cell behavior far away in the neuroectoderm?

6\) The conclusions rely on \"significant differences\" between experimental conditions determined by statistical tests. However, the effect sizes are often very small, and the variance within experimental groups is high. The low p values are a consequence of the very high sample numbers, but the biological significance of the determined effect sizes remains unclear. The authors should therefore apply bootstrapping or resampling methods using subsets from the data distributions to test whether the effect sizes are reproducible.

7\) It is unclear why embryos uniformly injected with *ndr2* give rise to polarized explants. It would be good to show that the presence of asymmetry does not depend on asymmetric injection of Nodal ligands, e.g. by executing in situ hybridization stainings with probes for injected *ndr2* (perhaps with a GFP tag or the like to distinguish it from endogenously produced Nodals). If injected *ndr2* is uniformly distributed, is Nodal autoactivation required for polarization, i.e. what happens in MZ*sqt*;*cyc* embryos?

8\) The authors state that \"Although the PCP genes *wnt5b*, *vangl2* (*trilobite*), and *gpc4* (*knypek*) were expressed at apparently normal levels in MZ*oep*-/- gastrulae by whole mount in situ hybridization (WISH) (Figure 2---figure supplement 1B)\", but the data does not show this; instead all genes seem to be upregulated in MZ*oep* embryos. Please adjust the conclusions.

10.7554/eLife.54445.sa2

Author response

> Essential revisions:
>
> 1\) The fact that the MZoep phenotype is worsened by the absence of Vangl2 indicates that both pathways are needed for ectoderm CE. Yet, it is not clear to what extent Nodal might also function upstream of PCP signaling. Especially, the evidence that PCP signaling is partially disrupted in MZoep mutants is not entirely convincing. To strengthen this conclusion, it would be good to test, for instance, (i) to what extent the MZoep CE phenotype can be rescued by PCP activation, and (ii) which aspect of PCP signaling (dynamic subcellular localization, expression level, turnover etc.) might partially depend on Nodal signaling.

Based on our studies of MZ*oep* mutants we propose that PCP signaling is partially active in the absence of Nodal signaling and that the two pathways work largely in parallel in vivo. However, two pieces of data indicate that PCP signaling is somewhat perturbed in MZ*oep*-/- gastrulae. First, whereas we show that WT and mutant cells exhibit comparable enrichment of Prickle-GFP at their anterior cell membranes, we also note that the mutant cells exhibit an increased proportion of Pk-GFP puncta that are not limited to anterior cell edges compared with WT (Figure 2A). This has proven to be our most reliable read-out of PCP signaling status during gastrulation, and demonstrates a mild PCP phenotype in Nodal-deficient mutants. Second, we have included new RNA-sequencing data directly comparing gene expression between stage matched MZ*oep*-/- and WT embryos at 90% epiboly stage. Analysis of these data demonstrates that the expression of most PCP genes is unchanged in MZ*oep*-/- compared to WTs, but the core PCP component *prickle1b* is significantly reduced in these mutants, again demonstrating a mild effect on PCP function. These data have been included as the new panel A in Figure 2---figure supplement 1 and are described within the Results section.

Processed RNA-sequencing data are included as Source Data Files 1 and 2, and raw sequence data have been deposited within the NCBI Gene Expression Omnibus under GEO Accession Number: GSE147302. These data can be accessed by reviewers prior to publication using the Reviewer Key wveduewuxlknfmp.

Finally, our investigations of blastoderm explants indicate that PCP signaling functions downstream of Nodal in ML cell polarization and explant extension (Figure 5).

While we agree that it would be ideal to suppress the Nodal loss-of-function phenotype by activating PCP signaling, this experiment is not feasible to our knowledge. There are no reliable downstream targets of PCP signaling that can be reliably manipulated during gastrulation.

> 2\) If CE is affected by loss of Nodal activity, a widening of the neural plate would be expected similar to the findings for the vangl2 MO. However, MZoep embryos actually have narrower neural plates than WT (Figure 2E, F), undermining the proposal that Nodal regulates CE.

This is an interesting point. The articles first describing the phenotypes of Nodal-deficient mutant zebrafish embryos (including MZ*oep*) note that extension is almost completely blocked, but that the other gastrulation movements of epiboly and convergence are intact (1, 2). As the reviewer points out, convergence of the neuroectoderm is apparent, but why this results in a narrower neural plate than WT is not known. Further, although convergence within MZ*oep* mutants doubtless occurs, previous reports demonstrate that the speed and persistence of converging neural plate cells within MZ*oep* mutants are significantly reduced compared to WTs at post-gastrulation stages (3), providing experimental evidence for disrupted convergence as well as extension. To better characterize convergence and extension movements in MZ*oep*-/- gastrulae and compare them quantitatively to WTs, we have re-analyzed our 4D nuclear tracking data to evaluate cell displacement in the mediolateral (convergence) and anteroposterior (extension) dimensions independently. By plotting these directional displacement data against a cell's position within the embryo, characteristic slopes emerged representing convergence and extension movements, respectively. We also quantified absolute displacement along each axis in embryos of each genotype. Such analysis revealed that, although convergence was still apparent in MZ*oep*-/- mutants, cell displacement in the ML dimension was significantly reduced compared to WT. AP extension was also severely disrupted in terms of both absolute displacement and spatial organization of cell movements. These new analyses have been added to Figure 1 and are described within the Results section.

> Also, why are the markers in Figure 2E more intensely stained in MZoep embryos compared to WT?

Our new RNA-seq data comparing WT and MZ*oep*-/- gastrulae demonstrate that *dlx3b* is expressed at slightly higher levels in MZ*oep* mutants, which may account for stronger staining. This is further compounded by increased cell density resulting from reduced extension of the neuroectoderm in these mutants (2). We have included these RNA-seq expression data in the new panel D in Figure 2---figure supplement 1, and discuss it briefly within the Results section.

> 3\) The statement \"Orientation of MZoep-/- cellular protrusions was also only partially improved within WT hosts (Figure 1I)\" is not supported and should be adjusted, since the graphs in Figure 1H and I look similar. The finding that MZoep cells transplanted into wildtype hosts display nearly normal protrusion orientation is interesting. Does this depend on the polarization of the surrounding cells and would, for instance, wildtype ectoderm cells have a more random orientation of the protrusions when transplanted into MZoep?

To statistically analyze the orientation of protrusions, measured orientations were binned into one of 12 sectors (30° each, 360° total) which were then categorized as mediolateral (within 60° of horizontal), anteroposterior (within 60° of vertical), or neither (the remaining 120°). These bins have been color-coded on the rose diagrams of protrusive orientation in Figure 1M. The distribution of protrusions within each of these categories was then compared between experimental conditions using Chi-square tests. This analysis revealed that the distribution of protrusions in MZ*oep*-/- cells transplanted into WT hosts differed significantly from both MZ*oep*-/- to MZ*oep*-/- controls (p\<0.0001) and WT to WT controls (p=0.0053), showing that while the polarity of their protrusions was improved by a WT environment, they did not align to the same degree as WT cells. These results are described within the Results section, and this analysis is further described in the Materials and methods section.

That MZ*oep*-/- cells transplanted into the neuroectoderm of WT hosts exhibit significantly improved alignment of their cell bodies and orientation of protrusions indeed demonstrates a non-autonomous effect on planar cell polarization. While it would be interesting to know whether this is likewise true in the reciprocal experiment (WT donors in MZ*oep*-/- hosts), we hesitated to do this experiment because the results would be too difficult to interpret. When WT cells are transplanted into MZ*oep* mutants they tend to become mesoderm, and it would be difficult to confirm that donor cells were neuroectodermal (so as to compare "oranges with oranges").

> 4\) Using the blastoderm explants, the authors suggest that convergence movements in this ex vivo system depend on Nodal signaling and that Nodal acts upstream of PCP signaling. However, the extension of the explant or the alignments of the cells aren\'t necessarily a readout of convergence movements. To claim this, it would be necessary to show actual convergence movements of the cells.

To address this concern, we have performed automated 4D cell tracking within nuclear labeled explants both with and without ectopic *ndr2*. These data were analyzed in the same fashion as tracking data from intact embryos, and yielded remarkably similar results. Cell tracks within *ndr2*-expressing explants were observed moving inward from lateral positions while moving outward along the axis of extension, tell-tale signs of C&E. Further, by graphing displacement along each axis against cell positions, we see slopes that are very similar to those in WT embryos, all highly suggestive of C&E as the primary morphogenetic mechanism of explant extension. These data have been included as new panels G-K in Figure 3 and described within the Results section.

> Is it possible that elongation is promoted by a general increase in cell movements or differential proliferation?

To address the possibility of differential or localized proliferation, we manually annotated cell divisions within time-lapse series of nuclear labeled explants and plotted their locations with respect to the center of each explant. We found that cell divisions were concentrated along the axis of extension, and although this may partially reflect the elongated shape of *ndr2*-expressing explants, it suggests a possible role for cell divisions in ex vivo extension. However, the number of cell divisions during these stages of ex vivo development is relatively small. Furthermore, an article recently published in *eLife* demonstrated that blocking cell divisions in zebrafish blastoderm explants did not prevent their extension (4). We also did not observe a "hotspot" of proliferation that would indicate a region of outgrowth. Together these data suggest that differential proliferation may play a small role in explant extension, but is unlikely to contribute substantially. These data are shown in a new figure supplement, Figure 3---figure supplement 2, and described in the Results section.

> Is Prickle-GFP localization polarized in explants?

To evaluate Pk-GFP localization in intact embryos, sparse labeling was achieved by transplanting cells from embryos injected with RNA encoding Pk-GFP (and H2B-RFP) into host embryos. Due to their small size, such transplantations between explants were not feasible. As an alternative approach, we attempted to achieve sparse labeling in explants through mosaic injections into one of sixteen blastomeres, but failed to observe reliable Pk-GFP puncta.

> Furthermore, injection of Nodal ligands also induces the specification of endoderm and mesoderm, which are both lacking in the uninjected control. The activation of PCP signaling during the extension of the explant could be due to the presence of endoderm and mesoderm rather than due to the activity of Nodal signaling per se. Drug treatment to block Nodal signaling after acquisition of cell fate could be a possible experiment to discriminate whether continuous Nodal signaling activity is needed.

We in fact already performed this exact experiment, which was included in the second, co-submitted manuscript addressing mesoderm-independent roles for Nodal in C&E. Because this second manuscript was not recommended for publication, we moved these data into a new Figure 6 for the current revised manuscript. We indeed found that inhibition of Nodal signaling after mesoderm specification significantly reduces ex vivo extension, and further found that Nodal promotes extension of explants devoid of mesoderm marker expression. Together these results demonstrate that continuous Nodal signaling (per se) is required for full explant extension. This new Figure 6 is accompanied by 2 figure supplements, Figure 6---figure supplements 1 and 2, and is described in the Results section.

> The paper would also benefit from a clearer distinction between elongation and CE. This is crucial since the effect of Nodal could in principle be mostly on prechordal plate migration rather than CE.

We agree that the distinction between extension and C&E is important, as morphogenetic mechanisms other than C&E certainly contribute to AP extension. However, we find it unlikely the prechordal plate (ppl) migration contributes to explant extension for the following reasons:

1\) Highly extending explants from embryos injected with 10 pg of *ndr2* do not express markers for ppl, such as *gsc* (Figure 3---figure supplement 1).

2\) We observed expression of *gsc* in explants from embryos injected with higher doses of *ndr2* (25-100pg), but this appears to be inversely correlated with their degree of extension (Figure 3---figure supplement 1), arguing against the notion that explant extension is driven by prechordal plate migration.

> 5\) Nodal acts highly locally, not in a widespread manner throughout the embryo (see Figure 4---figure supplement 1 and Xu et al., 2014). How would Nodal regulate cell behavior far away in the neuroectoderm?

Van Boxtel at al., 2015 (5) demonstrate that there is low-level activation of downstream Nodal signaling within the zebrafish neural plate at gastrulation stages. Moreover, Sampath et al., 1998 (6), showed that *cyc/ndr2* is expressed in the axial mesoderm up to 90% epiboly -- thus, just below the neuroectoderm undergoing C&E.

> 6\) The conclusions rely on \"significant differences\" between experimental conditions determined by statistical tests. However, the effect sizes are often very small, and the variance within experimental groups is high. The low p values are a consequence of the very high sample numbers, but the biological significance of the determined effect sizes remains unclear. The authors should therefore apply bootstrapping or resampling methods using subsets from the data distributions to test whether the effect sizes are reproducible.

As in any complex living system, cell shape, alignment, and movements are (expectedly) highly variable within live embryos. This is why we have quantified -- as the reviewer noted -- a large number of cells and/or embryos for every experiment. However, we disagree that the resulting effect sizes are small or insignificant. Although the difference between an orientation of 20° and 45° may not sound substantial, it is the difference between a highly polarized (20°) and randomly oriented (45°) cell. And while not every cell in even a WT embryo will achieve this level of polarization, our statistics demonstrate that *as a population,* these cells are highly polarized and mutant cells are significantly less so. In the relevant figures, we included individual data points for all of our cell and explant measurements to be transparent about exactly how variable this type of data is. However, these plots can be misleading, and suggest, for example, that populations of cells are less well polarized than they are. To better represent differences between groups, in the revised manuscript we have changed our graphical representations of cell shape and alignment (in Figures 1, 2, and 5) to violin plots. Individual data points are still included, but we feel these plots more clearly illustrate the "shape" of each dataset as a whole and highlight important differences between them. One example is shown in Figure 1J.

> 7\) It is unclear why embryos uniformly injected with ndr2 give rise to polarized explants. It would be good to show that the presence of asymmetry does not depend on asymmetric injection of Nodal ligands, e.g. by executing in situ hybridization stainings with probes for injected ndr2 (perhaps with a GFP tag or the like to distinguish it from endogenously produced Nodals).

We indeed speculate that small asymmetries resulting from injection are amplified by feed-back and feed-forward Nodal signaling (7), as it is not possible to ensure perfectly uniform distribution of injected RNA. This is because 1) we are injecting a small 1 nL volume into an embryo with a 600 mm diameter, and we will rarely hit the exact center, and 2) we have no control over cytoplasmic streaming, which distributes cytoplasm and injected RNAs between the cells of the early embryo. We have included a small section in the Discussion section describing this speculated source of asymmetry (fifth paragraph). While we are certainly curious to discover the origins of this asymmetry in future studies, we do not feel that how the asymmetry arises in any way affects our interpretation of the data presented nor any conclusions drawn therefrom.

> If injected ndr2 is uniformly distributed, is Nodal autoactivation required for polarization, i.e. what happens in MZsqt;cyc embryos?

Although we speculate that in our injected experimental embryos Nodal may not be evenly distributed, we would be similarly excited to perform this experiment to dissect the role of Nodal autoactivation. However, given that this experiment would require the arduous task of germline transplantation to make MZ mutants, we had neither the time nor resources to complete it in a timely manner.

> 8\) The authors state that \"Although the PCP genes wnt5b, vangl2 (trilobite), and gpc4 (knypek) were expressed at apparently normal levels in MZoep-/- gastrulae by whole mount in situ hybridization (WISH) (Figure 2---figure supplement 1B)\", but the data does not show this; instead all genes seem to be upregulated in MZoep embryos. Please adjust the conclusions.

As mentioned above, we have since included RNA-seq data demonstrating that most PCP genes, including *wnt5b,vangl2*, and *gpc4*, are expressed at normal levels in MZ*oep* mutants.
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